Logo image of VATE

INNOVATE CORP (VATE) Stock Fundamental Analysis

NYSE:VATE - New York Stock Exchange, Inc. - US45784J3032 - Common Stock - Currency: USD

10.7  +0.61 (+6.05%)

Fundamental Rating

1

VATE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 45 industry peers in the Construction & Engineering industry. Both the profitability and financial health of VATE have multiple concerns. VATE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year VATE has reported negative net income.
VATE had a positive operating cash flow in the past year.
VATE had negative earnings in each of the past 5 years.
VATE had a positive operating cash flow in 4 of the past 5 years.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.18%, VATE is doing worse than 79.55% of the companies in the same industry.
The Return On Invested Capital of VATE (10.05%) is better than 77.27% of its industry peers.
Industry RankSector Rank
ROA -3.18%
ROE N/A
ROIC 10.05%
ROA(3y)-9.47%
ROA(5y)-6.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 300

1.3 Margins

VATE has a Operating Margin (4.43%) which is in line with its industry peers.
VATE has a Gross Margin (18.15%) which is in line with its industry peers.
In the last couple of years the Gross Margin of VATE has declined.
Industry RankSector Rank
OM 4.43%
PM (TTM) N/A
GM 18.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-5.18%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so VATE is still creating some value.
Compared to 1 year ago, VATE has less shares outstanding
VATE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for VATE is higher compared to a year ago.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that VATE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VATE (0.77) is worse than 90.91% of its industry peers.
The Debt to FCF ratio of VATE is 54.89, which is on the high side as it means it would take VATE, 54.89 years of fcf income to pay off all of its debts.
VATE has a worse Debt to FCF ratio (54.89) than 70.45% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 54.89
Altman-Z 0.77
ROIC/WACC1.41
WACC7.14%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.85 indicates that VATE may have some problems paying its short term obligations.
With a Current ratio value of 0.85, VATE is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
A Quick Ratio of 0.81 indicates that VATE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.81, VATE is doing worse than 84.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.81
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

0

3. Growth

3.1 Past

The earnings per share for VATE have decreased strongly by -275.44% in the last year.
VATE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.30%.
VATE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.36% yearly.
EPS 1Y (TTM)-275.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1211.09%
Revenue 1Y (TTM)-16.3%
Revenue growth 3Y25.68%
Revenue growth 5Y-6.36%
Sales Q2Q%-35.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VATE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

95.45% of the companies in the same industry are more expensive than VATE, based on the Enterprise Value to EBITDA ratio.
VATE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VATE is cheaper than 88.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.26
EV/EBITDA 8.83
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VATE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INNOVATE CORP

NYSE:VATE (1/24/2025, 1:14:26 PM)

10.7

+0.61 (+6.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-03 2025-03-03
Inst Owners20.44%
Inst Owner Change2.88%
Ins Owners53.32%
Ins Owner Change-102.83%
Market Cap141.88M
Analysts82.86
Price TargetN/A
Short Float %5.61%
Short Ratio6.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-23.48%
DP-4.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF 11.26
P/OCF 4.91
P/B N/A
P/tB N/A
EV/EBITDA 8.83
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.95
FCFY8.88%
OCF(TTM)2.18
OCFY20.37%
SpS92.87
BVpS-11.09
TBVpS-33.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.18%
ROE N/A
ROCE 12.72%
ROIC 10.05%
ROICexc 11.41%
ROICexgc 55.51%
OM 4.43%
PM (TTM) N/A
GM 18.15%
FCFM 1.02%
ROA(3y)-9.47%
ROA(5y)-6.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-5.18%
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 54.89
Debt/EBITDA 5.73
Cap/Depr 49.24%
Cap/Sales 1.32%
Interest Coverage 1.11
Cash Conversion 32.95%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.81
Altman-Z 0.77
F-Score5
WACC7.14%
ROIC/WACC1.41
Cap/Depr(3y)54.75%
Cap/Depr(5y)66.28%
Cap/Sales(3y)1.52%
Cap/Sales(5y)2.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-275.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1211.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.3%
Revenue growth 3Y25.68%
Revenue growth 5Y-6.36%
Sales Q2Q%-35.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y155.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.5%
FCF growth 3Y-43.16%
FCF growth 5Y-51.5%
OCF growth 1Y194.44%
OCF growth 3Y-24.63%
OCF growth 5Y-40.02%